Algo version: 0.98b
Axsome Therapeutics Inc is listed at the LSE Exchange
Axsome Therapeutics Inc [0HKF.L]
LSE Sector: Healthcare Industry:Medical Pharmaceuticals

Is Axsome Therapeutics Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Axsome Therapeutics Inc 10 years ago, but if you had invested on Tuesday 1st of February 2022 when the price was $3.35, you would have made a profit of $92.68 per share or 2 766.57%

No, the average daily trading liquidity for Axsome Therapeutics Inc is $562 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Axsome Therapeutics Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Axsome Therapeutics Inc to be high [0.85 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.